A study to compare two Ayurvedic nasal therapies with external treatments for reducing neck pain and disability in patients with cervical spondylosis

A Randomised Open-Label Comparative Clinical Study to Evaluate the Efficacy of Nasya Karma with Upanaha and Nasya Karma with Jambira Pinda Swedana in the Management of Cervical Spondylosis - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/100582

Enrollment

Registered

2026-01-08

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M479- Spondylosis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of age group 18-65 yrs of either gender. 2.Patients with any 2 or more Clinical features of cervical spondylosis, like: a.Chronic or recurrent neck pain b.Neck stiffness c.Decreased Range of Motion d.Headache e.Radiating pain 3.Patients fit for Nasya Karma and localized Swedana karma over Neck region. 4.MRI evidence of degenerative changes in the cervical spine, including any of the following: Disc degeneration, Disc bulge or protrusion, Disc herniation.

Exclusion criteria

Exclusion criteria: 1.Patients who are contraindicated for ShiroVirechana Nasya such as Pregnant women and lactating mothers, chronic rhinitis, etc. 2.Patients with renal or hepatic impairment (Sr. creatinine greater than 1.8 mgdl, SGOT and SGPT greater than THREE times of upper limit. 3.Patient having history of cervical instability, cord compression, central pain syndrome, cervical myelopathy, radiculopathy, compressive myelopathy, and muscle wasting, 4.Patients with comorbid conditions such as Hypertension (systolic greater than 160 mm Hg and diastolic greater than 100 mm Hg despite antihypertensive medications) and Diabetes Mellitus (having HbA1c greater than 7 percentage with or without oral hypoglycaemic medication). 5.Any medical red flag i.e. Spinal tumour, fracture, metabolic diseases, RA, spinal infection etc. 6.Patients requiring emergency treatment.

Design outcomes

Primary

Measure	Time frame
Primary Outcome will be measured by proportion of patients showing improvement post-treatment assessed through Neck Disability Questionnaire .Timepoint: Baseline,day 15,day 30	—

Secondary

Measure	Time frame
Secondary Outcome shall be measured though MRI of Cervical spine and assessed through Vas Score and Range of Motion measured with Goniometer.Timepoint: Baseline,day 15,day 30	—

Countries

India

Contacts

Public ContactDr. Akash Goel

Ayurvedic and Unani Tibbia College and Hospital

nitjin2005@gmail.com9811765501

Outcome results